Gastroenterology
Volume 136, Issue 7 , Pages 2068-2073 , June 2009

Next-Generation Stool DNA Testing: Expanding the Scope

  • David A. Ahlquist

      Affiliations

    • Corresponding Author InformationReprint requests Address requests for reprints to: David A. Ahlquist, MD, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905. fax: (507) 266-0350

References 

  1. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58:130–160
  2. Whitlock EP, Lin JS, Liles E, et al. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:638–658
  3. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med. 2004;351:2704–2714
  4. Ahlquist DA, Sargent DJ, Loprinzi CL, et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med. 2008;149:441–450
  5. Dressman D, Yan H, Traverso G, et al. Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations. Proc Natl Acad Sci U S A. 2003;100:8817–8822
  6. Diehl F, Li M, Dressman D, et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci U S A. 2005;102:16368–16373
  7. Diehl F, Schmidt K, Durkee KH, et al. Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients. Gastroenterology. 2008;135:489–498
  8. Zou H, Taylor WR, Harrington JJ, et al. High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay. Gastroenterology. 2009;136:459–470
  9. Kann L, Han J, Ahlquist D, et al. Improved marker combination for detection of de novo genetic variation and aberrant DNA in colorectal neoplasia. Clin Chem. 2006;52:2299–2302
  10. Itzkowitz SH, Jandorf L, Brand R, et al. Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol. 2007;5:111–117
  11. Zou H, Harrington JJ, Cao X, et al. Quantitative stool DNA testing for detection of both colorectal cancer and advanced adenoma. JX Gastroenterology. 2009;In press.
  12. Zou H, Harrington JJ, Klatt KK, et al. A sensitive method to quantify human long DNA in stool: relevance to colorectal cancer screening. Cancer Epidemiol Biomarkers Prev. 2006;15:1115–1119
  13. Olson J, Whitney DH, Durkee K, et al. DNA stabilization is critical for maximizing performance of fecal DNA-based colorectal cancer tests. Diagn Mol Pathol. 2005;14:183–191
  14. Zou H, Taylor WR, Devens ME, et al. Pan-detection of gastrointestinal neoplasms by stool DNA testing: establishment of feasibility. HJ Gastroenterology. 2009;In press
  15. Johnson CD, Chen MH, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med. 2008;359:1207–1217
  16. Ahlquist DA, Wieand HS, Moertel CG, et al. Accuracy of fecal occult blood screening for colorectal neoplasia (A prospective study using Hemoccult and HemoQuant tests). JAMA. 1993;269:1262–1267
  17. Morikawa T, Kato J, Yamaji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129:422–428
  18. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–1477
  19. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood (Minnesota Colon Cancer Control Study). N Engl J Med. 1993;328:1365–1371
  20. Kronborg O, Jorgensen OD, Fenger C, et al. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol. 2004;39:846–851
  21. Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1–8
  22. Ahlquist DA YG. Approach to the patient with occult gastrointestinal bleeding. In:  Yamada T editors. Principles of clinical gastroenterology. Chichester: Wiley-Blackwell; 2008;p. 152–169
  23. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96
  24. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108
  25. Winter JM, Cameron JL, Lillemoe KD, et al. Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosis. Ann Surg. 2006;243:673–680
  26. Ahlquist DA, Harrington JJ, Burgart LJ, et al. Morphometric analysis of the “mucocellular layer” overlying colorectal cancer and normal mucosa: relevance to exfoliation and stool screening. Hum Pathol. 2000;31:51–57
  27. Yamaguchi K, Nakamura M, Shirahane K, et al. Pancreatic juice cytology in IPMN of the pancreas. Pancreatology. 2005;5:416–421
  28. Baskin-Bey ES, Moreno Luna LE, Gores GJ. Diagnosis of cholangiocarcinoma in patients with PSC: a sight on cytology. J Hepatol. 2006;45:476–479
  29. Taylor WR, Mahoney DW, Middha S, et al. DNA markers for the pan-detection and site-prediction of aerodigestive cancers: evaluation of a candidate panel. HJ Gastroenterology. 2009;In press.
  30. Caldas C, Hahn SA, Hruban RH, et al. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res. 1994;54:3568–3573
  31. Molina JR. Detection of pancreatic cancer by assay of DNA alterations in stool. AD Gastroenterology. 2004;126:A24
  32. Ahlquist DA CA, Jett J, Pearson RK, et al. Universal detection of aerodigestive cancers by assay of nonapoptotic human DNA in stool. Gastroenterology. 2000;118(Suppl 2):A40

 Conflict of interest Dr Alquist has, or has filed patents related to stool DNA testing and the detection of gastrointestinal neoplasms.

PII: S0016-5085(09)00570-8

doi: 10.1053/j.gastro.2009.04.025

Gastroenterology
Volume 136, Issue 7 , Pages 2068-2073 , June 2009

Article Tools

* Image Usage & Resolution